Skip Navigation

The European Journal of Public Health 2003 13(Supplement 1):51-54; doi:10.1093/eurpub/13.suppl_1.51
© 2003 by European Journal of Public Health
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by de Beaufort, C.E.
Right arrow Articles by Tolis, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Beaufort, C.E.
Right arrow Articles by Tolis, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Union diabetes indicators

Fact or fiction?

C.E. de Beaufort1,*, A. Reunanen2, V. Raleigh3, F. Storms4, L. Kleinebreil5, R. Gallego6, C. Giorda7, K. Midthjell8, M. Jecht9, I. de Leeuw, E. Schober11, G. Boran12 and G. Tolis13

1 Clinique Pédiatrique Luxemburg, GDLuxemburg 2 National Public Health Institute, Helsinki, Finland 3 Commission for Health Improvement, London, UK 4 MESOS Diabetes Centrum, Bilthoven, the Netherlands 5 Hopital G Pompidou, Paris, France 6 Ministry of Health, Lisbon, Portugal 7 Ospedale Maggiore, Chieri, Italy 8 The Norwegian University of Science and Technology, Verdal, Norway 9 GK Havelhohe Med Klinik/Diabetologie, Berlin, Germany 10 University Hospital Antwerp, Belgium 11 University Children's Hospital, Vienna, Austria 12 Adelaide and Health Hospital, Dublin, Ireland 13 Hippokratis General Hospital, Athens, Greece

Diabetes mellitus is one of the major causes of morbidity and mortality in EU/EFTA countries. Monitoring risk factors for diabetes and its complications will offer the possibility to evaluate the development in time as well as the influence of possible interventions. In this investigation a list with core and secondary indicators is proposed. Availability of these indicators and their data sources is discussed. An important variability of data sources is used in EU/EFTA countries, interfering with the comparability of the outcome. Further harmonisation as well as continuous evaluation of data sources will be necessary to provide reliable tools to monitor diabetes mellitus and its outcome on a routine basis.

Keywords: complications, diabetes mellitus, European Union, indicators

* Correspondence: Dr C.E. de Beaufort, Clinique Pédiatrique, 4 rue Barblé, 1210 Luxembourg, GD de Luxembourg, e-mail: debeaufort.carine{at}chl.lu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Occup. Environ. Med.Home page
F G Benavides
Ill health, social protection, labour relations, and sickness absence.
Occup. Environ. Med., April 1, 2006; 63(4): 228 - 229.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.